Publication | Closed Access
Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial
143
Citations
0
References
2002
Year
Randomized Clinical TrialPharmacotherapySurgeryOsteoporosisOrthopaedic SurgeryBone DiseaseClinical TrialsOrthopaedicsGeriatric Fracture CareRheumatoid ArthritisRheumatologyBone HealthMultiple OutcomesPharmacologyRaloxifene Evaluation TrialSpinal FracturePostmenopausal WomenMedicineFour-year Results
The Multiple Outcomes of Raloxifene Evaluation trial studied 7705 postmenopausal women with osteoporosis randomized to placebo, or raloxifene 60 or 120 mg/d [JAMA 282(1999): 637]. This report assesses the efficacy of raloxifene on the long-term cumulative incidence new vertebral fractures through 4 yr.